SCHEMBL7989377

SCHEMBL7989377

CCCc1nc(O)c2c(ncn2Cc2ccc(C)cc2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
CYP11B1 P15538 2/20 0.44
CYP11B2 P19099 2/20 0.44
HTT P42858 2/20 0.44
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35
MET P08581 2/20 0.34
HPGD P15428 1/20 0.34
TLR7 Q9NYK1 2/20 0.34
KCNH2 Q12809 1/20 0.34
TSHR P16473 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
ALDH1A1 P00352 1/20 0.34
NR3C1 P04150 1/20 0.34
TRPA1 O75762 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7987434 0.91 CYP11B1 (0.42) LMNASMN1; SMN2CYP11B1CYP11B2HTT
SCHEMBL7975137 0.90 LMNA (0.42) LMNASMN1; SMN2CYP11B1CYP11B2HTT
SCHEMBL7988957 0.89 MET (0.45) LMNASMN1; SMN2CYP11B1CYP11B2HTT
SCHEMBL7989407 0.88 HPGD (0.44) SMN1; SMN2CYP11B1CYP11B2HTTHPGD
SCHEMBL7974256 0.87 CNOT7 (0.40) LMNASMN1; SMN2CYP11B1HTTTP53
SCHEMBL7985733 0.86 MEN1 (0.47) SMN1; SMN2TP53MAPTHPGDMEN1
SCHEMBL7984746 0.86 ABCC8 (0.46) SMN1; SMN2CYP11B1CYP11B2METHPGD
SCHEMBL7988660 0.85 CYP11B1 (0.49) LMNASMN1; SMN2CYP11B1CYP11B2HTT
SCHEMBL7988035 0.85 SMN1; SMN2 (0.39) LMNASMN1; SMN2CYP11B1CYP11B2HTT
Hydrochloric Acid SCHEMBL7988141 0.84 SMN1; SMN2 (0.39) LMNASMN1; SMN2CYP11B1CYP11B2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed